Only concern for me is the relationship with Carestream.
1. Their Nano sales have been disappointing and underwhelming
2. They are no longer actively engaged in Australian and European markets.
The Company have said they’re looking to establish a new sales strategy independent from Carestream. Interested to see how this plays out - one of the key risks at the moment.
